目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 32)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
TABLE 1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
TABLE 2 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
1.5 STAKEHOLDERS
1.6 LIMITATIONS

2 RESEARCH METHODOLOGY (Page No. - 36)
2.1 RESEARCH DATA
FIGURE 1 MULTIPLEX ASSAYS MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.2 PRIMARY DATA
2.2.1 KEY DATA FROM PRIMARY SOURCES
2.2.1.1 Key data from primary sources
2.2.1.2 Key industry insights
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
FIGURE 3 MULTIPLEX ASSAYS MARKET - REVENUE SHARE ANALYSIS ILLUSTRATION: ILLUMINA, INC.
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF MULTIPLEX ASSAY PRODUCTS
FIGURE 5 CAGR PROJECTIONS
FIGURE 6 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4.1 SECONDARY DATA
2.4.2 PRIMARY DATA
2.5 DATA TRIANGULATION METHODOLOGY
FIGURE 7 DATA TRIANGULATION
2.6 MARKET SHARE ANALYSIS
2.7 ASSUMPTIONS FOR THE STUDY
2.8 INDICATORS AND ASSUMPTIONS AND THEIR IMPACT ON THE STUDY
2.8.1 COVID-19-SPECIFIC ASSUMPTIONS
2.9 LIMITATIONS
2.10 RISK ASSESSMENT
TABLE 3 RISK ASSESSMENT
2.11 COVID-19 HEALTH ASSESSMENT
2.12 COVID-19 ECONOMIC ASSESSMENT
2.13 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
2.14 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE MULTIPLEX ASSAYS MARKET

3 EXECUTIVE SUMMARY (Page No. - 56)
FIGURE 10 MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD BILLION)
FIGURE 11 MULTIPLEX ASSAYS MARKET, BY TYPE, 2021 VS. 2026 (USD BILLION )
FIGURE 12 MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD BILLION)
FIGURE 13 MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2021 VS. 2026 (USD BILLION )
FIGURE 14 MULTIPLEX ASSAYS MARKET, BY END USER, 2021 VS. 2026 (USD BILLION)
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF THE MULTIPLEX ASSAYS MARKET (2021-2026)

4 PREMIUM INSIGHTS (Page No. - 60)
4.1 MULTIPLEX ASSAYS MARKET OVERVIEW
FIGURE 16 INCREASING ADOPTION OF MULTIPLEX ASSAYS IN COMPANION DIAGNOSTICS TO DRIVE THE MARKET GROWTH
4.2 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY APPLICATION AND COUNTRY (2020)
FIGURE 17 R&D TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICAN MULTIPLEX ASSAYS MARKET IN 2020
4.3 MULTIPLEX ASSAYS MARKET, BY REGION (2021 VS. 2026)
FIGURE 18 NORTH AMERICA TO DOMINATE THE MULTIPLEX ASSAYS MARKET IN 2026
4.4 GEOGRAPHICAL SNAPSHOT OF THE MULTIPLEX ASSAYS MARKET
FIGURE 19 APAC TO BE THE FASTEST-GROWING MARKET FROM 2021 TO 2026

5 MARKET OVERVIEW (Page No. - 63)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 GLOBAL MULTIPLEX ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing use of multiplex assays in companion diagnostics
5.2.1.2 Increasing advantages over singleplex and traditional assays
5.2.1.3 Increasing incidence of chronic and infectious diseases and growing awareness about early disease diagnosis
FIGURE 21 INCIDENCE OF DIABETES, BY REGION, 2019, 2030, AND 2045
TABLE 4 GLOBAL INCIDENCE OF INFECTIOUS DISEASES
TABLE 5 APPROVED AND LAUNCHED MULTIPLEX ASSAYS FOR THE DIAGNOSIS OF SARS-COV-2
5.2.2 RESTRAINTS
5.2.2.1 Increasing costs of equipment
5.2.2.2 Growing number of stringent regulations and standards
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing validation of biomarkers in molecular and protein diagnostics
5.2.3.2 Rising need for high-throughput and automated systems
5.2.4 CHALLENGES
5.2.4.1 Increasing dearth of skilled professionals

6 MULTIPLEX ASSAYS MARKET, BY PRODUCT AND SERVICE (Page No. - 70)
6.1 INTRODUCTION
TABLE 6 MULTIPLEX ASSAYS MARKET, BY PRODUCT AND SERVICE, 2016-2020 (USD MILLION)
TABLE 7 MULTIPLEX ASSAYS MARKET, BY PRODUCT AND SERVICE, 2021-2026 (USD MILLION)
6.2 CONSUMABLES
TABLE 8 MULTIPLEX ASSAY CONSUMABLES MARKET, BY REGION, 2016-2020 (USD MILLION)
TABLE 9 MULTIPLEX ASSAY CONSUMABLES MARKET, BY REGION, 2021-2026 (USD MILLION)
TABLE 10 NORTH AMERICA: MULTIPLEX ASSAY CONSUMABLES MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 11 NORTH AMERICA: MULTIPLEX ASSAY CONSUMABLES MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
6.3 INSTRUMENTS
TABLE 12 MULTIPLEX ASSAY INSTRUMENTS MARKET, BY REGION, 2016-2020 (USD MILLION)
TABLE 13 MULTIPLEX ASSAY INSTRUMENT MARKET, BY REGION, 2021-2026 (USD MILLION)
TABLE 14 NORTH AMERICA: MULTIPLEX ASSAY INSTRUMENTS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 15 NORTH AMERICA: MULTIPLEX ASSAY INSTRUMENTS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
6.4 SOFTWARE & SERVICES
TABLE 16 MULTIPLEX ASSAY SOFTWARE & SERVICES MARKET, BY REGION, 2016-2020 (USD MILLION)
TABLE 17 MULTIPLEX ASSAY SOFTWARE & SERVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
TABLE 18 NORTH AMERICA: MULTIPLEX ASSAY SOFTWARE & SERVICES MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 19 NORTH AMERICA: MULTIPLEX ASSAY SOFTWARE & SERVICES MARKET, BY COUNTRY, 2021-2026 (USD MILLION)

7 MULTIPLEX ASSAYS MARKET, BY TYPE (Page No. - 77)
7.1 INTRODUCTION
TABLE 20 MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2020 (USD MILLION)
TABLE 21 MULTIPLEX ASSAYS MARKET, BY TYPE, 2021-2026 (USD MILLION)
7.2 PROTEIN MULTIPLEX ASSAYS
TABLE 22 PROTEIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2020 (USD MILLION)
TABLE 23 PROTEIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 24 PROTEIN MULTIPLEX ASSAYS MARKET, BY REGION, 2016-2020 (USD MILLION)
TABLE 25 PROTEIN MULTIPLEX ASSAYS MARKET, BY REGION, 2021-2026(USD MILLION)
TABLE 26 NORTH AMERICA: PROTEIN MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 27 NORTH AMERICA: PROTEIN MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
7.2.1 PLANAR PROTEIN ASSAYS
TABLE 28 PLANAR PROTEIN ASSAYS MARKET, BY REGION, 2016-2020 (USD MILLION)
TABLE 29 PLANAR PROTEIN ASSAYS MARKET, BY REGION, 2021-2026(USD MILLION)
TABLE 30 NORTH AMERICA: PLANAR PROTEIN ASSAYS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 31 NORTH AMERICA: PLANAR PROTEIN ASSAYS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
7.2.2 BEAD-BASED PROTEIN ASSAYS
TABLE 32 BEAD-BASED PROTEIN ASSAYS MARKET, BY REGION, 2016-2020 (USD MILLION)
TABLE 33 BEAD-BASED PROTEIN ASSAYS MARKET, BY REGION, 2021-2026 (USD MILLION)
TABLE 34 NORTH AMERICA: BEAD-BASED PROTEIN ASSAYS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 35 NORTH AMERICA: BEAD-BASED PROTEIN ASSAYS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
7.2.3 OTHER PROTEIN ASSAYS
TABLE 36 OTHER PROTEIN ASSAYS MARKET, BY REGION, 2016-2020 (USD MILLION)
TABLE 37 OTHER PROTEIN ASSAYS MARKET, BY REGION, 2021-2026(USD MILLION)
TABLE 38 NORTH AMERICA: OTHER PROTEIN ASSAYS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 39 NORTH AMERICA: OTHER PROTEIN ASSAYS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
7.3 NUCLEIC ACID MULTIPLEX ASSAYS
TABLE 40 SOME OF THE FDA AUTHORIZED MULTIPLEX ASSAYS AND INSTRUMENTS AUTHORIZED FOR THE SIMULTANEOUS DETECTION OF INFLUENZA VIRUSES AND SARS-COV-2
TABLE 41 NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2020 (USD MILLION)
TABLE 42 NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 43 NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY REGION, 2016-2020 (USD MILLION)
TABLE 44 NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY REGION, 2021-2026 (USD MILLION)
TABLE 45 NORTH AMERICA: NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 46 NORTH AMERICA: NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
7.3.1 PLANAR NUCLEIC ACID ASSAYS
TABLE 47 PLANAR NUCLEIC ACID ASSAYS MARKET, BY REGION, 2016-2020 (USD MILLION)
TABLE 48 PLANAR NUCLEIC ACID ASSAYS MARKET, BY REGION, 2021-2026 (USD MILLION)
TABLE 49 NORTH AMERICA: PLANAR NUCLEIC ACID ASSAYS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 50 NORTH AMERICA: PLANAR NUCLEIC ACID ASSAYS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
7.3.2 BEAD-BASED NUCLEIC ACID ASSAYS
TABLE 51 BEAD-BASED NUCLEIC ACID ASSAYS MARKET, BY REGION, 2016-2020 (USD MILLION)
TABLE 52 BEAD-BASED NUCLEIC ACID ASSAYS MARKET, BY REGION, 2021-2026 (USD MILLION)
TABLE 53 NORTH AMERICA: BEAD-BASED NUCLEIC ACID ASSAYS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 54 NORTH AMERICA: BEAD-BASED NUCLEIC ACID ASSAYS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
7.3.3 OTHER NUCLEIC ACID ASSAYS
TABLE 55 OTHER NUCLEIC ACID ASSAYS MARKET, BY REGION, 2016-2020 (USD MILLION)
TABLE 56 OTHER NUCLEIC ACID ASSAYS MARKET, BY REGION, 2021-2026 (USD MILLION)
TABLE 57 NORTH AMERICA: OTHER NUCLEIC ACID ASSAYS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 58 NORTH AMERICA: OTHER NUCLEIC ACID ASSAYS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
7.4 CELL-BASED MULTIPLEX ASSAYS
TABLE 59 CELL-BASED MULTIPLEX ASSAYS MARKET, BY REGION, 2016-2020 (USD MILLION)
TABLE 60 CELL-BASED MULTIPLEX ASSAYS MARKET, BY REGION, 2021-2026 (USD MILLION)
TABLE 61 NORTH AMERICA: CELL-BASED MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 62 NORTH AMERICA: CELL-BASED MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)

8 MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY (Page No. - 97)
8.1 INTRODUCTION
TABLE 63 MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2020 (USD MILLION)
TABLE 64 MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2021-2026 (USD MILLION)
8.2 FLOW CYTOMETRY
TABLE 65 MULTIPLEX ASSAYS MARKET FOR FLOW CYTOMETRY, BY REGION, 2016-2020 (USD MILLION)
TABLE 66 MULTIPLEX ASSAYS MARKET FOR FLOW CYTOMETRY, BY REGION, 2021-2026 (USD MILLION)
TABLE 67 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 68 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2021-2026 (USD MILLION)
8.3 FLUORESCENCE DETECTION
TABLE 69 MULTIPLEX ASSAYS MARKET FOR FLUORESCENCE DETECTION, BY REGION, 2016-2020 (USD MILLION)
TABLE 70 MULTIPLEX ASSAYS MARKET FOR FLUORESCENCE DETECTION, BY REGION, 2021-2026 (USD MILLION)
TABLE 71 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR FLUORESCENCE DETECTION, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 72 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR FLUORESCENCE DETECTION, BY COUNTRY, 2021-2026 (USD MILLION)
8.4 LUMINESCENCE
TABLE 73 MULTIPLEX ASSAYS MARKET FOR LUMINESCENCE, BY REGION, 2016-2020 (USD MILLION)
TABLE 74 MULTIPLEX ASSAYS MARKET FOR LUMINESCENCE, BY REGION, 2021-2026 (USD MILLION)
TABLE 75 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR LUMINESCENCE, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 76 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR LUMINESCENCE, BY COUNTRY, 2021-2026 (USD MILLION)
8.5 MULTIPLEX REAL-TIME PCR
TABLE 77 MULTIPLEX ASSAYS MARKET FOR MULTIPLEX RT PCR, BY REGION, 2016-2020 (USD MILLION)
TABLE 78 MULTIPLEX ASSAYS MARKET FOR MULTIPLEX RT PCR, BY REGION, 2021-2026 (USD MILLION)
TABLE 79 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR MULTIPLEX RT PCR, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 80 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR MULTIPLEX RT PCR, BY COUNTRY, 2021-2026 (USD MILLION)
8.6 OTHER TECHNOLOGIES
TABLE 81 MULTIPLEX ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2016-2020 (USD MILLION)
TABLE 82 MULTIPLEX ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021-2026 (USD MILLION)
TABLE 83 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 84 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2026 (USD MILLION)

9 MULTIPLEX ASSAYS MARKET, BY APPLICATION (Page No. - 109)
9.1 INTRODUCTION
TABLE 85 MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
TABLE 86 MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
9.2 RESEARCH & DEVELOPMENT
TABLE 87 MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2016-2020 (USD MILLION)
TABLE 88 MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2021-2026 (USD MILLION)
TABLE 89 MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2016-2020 (USD MILLION)
TABLE 90 MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2021-2026 (USD MILLION)
TABLE 91 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 92 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2021-2026 (USD MILLION)
9.2.1 DRUG DISCOVERY & DEVELOPMENT
TABLE 93 MULTIPLEX ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2016-2020 (USD MILLION)
TABLE 94 MULTIPLEX ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021-2026 (USD MILLION)
TABLE 95 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 96 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021-2026 (USD MILLION)
9.2.2 BIOMARKER DISCOVERY & VALIDATION
TABLE 97 MULTIPLEX ASSAYS MARKET FOR BIOMARKER DISCOVERY & VALIDATION, BY REGION, 2016-2020 (USD MILLION)
TABLE 98 MULTIPLEX ASSAYS MARKET FOR BIOMARKER DISCOVERY & VALIDATION, BY REGION, 2021-2026 (USD MILLION)
TABLE 99 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR BIOMARKER DISCOVERY & VALIDATION, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 100 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR BIOMARKER DISCOVERY & VALIDATION, BY COUNTRY, 2021-2026 (USD MILLION)
9.3 CLINICAL DIAGNOSTICS
TABLE 101 MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2016-2020 (USD MILLION)
TABLE 102 MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021-2026 (USD MILLION)
TABLE 103 MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2016-2020 (USD MILLION)
TABLE 104 MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2021-2026 (USD MILLION)
TABLE 105 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 106 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021-2026 (USD MILLION)
9.3.1 INFECTIOUS DISEASES
TABLE 107 MULTIPLEX ASSAYS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2016-2020 (USD MILLION)
TABLE 108 MULTIPLEX ASSAYS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2021-2026 (USD MILLION)
TABLE 109 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 110 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2021-2026 (USD MILLION)
9.3.2 CANCER
TABLE 111 INCREASING INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
TABLE 112 MULTIPLEX ASSAYS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2016-2020 (USD MILLION)
TABLE 113 MULTIPLEX ASSAYS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2021-2026 (USD MILLION)
TABLE 114 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 115 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2021-2026 (USD MILLION)
9.3.3 CARDIOVASCULAR DISEASES
TABLE 116 MULTIPLEX ASSAYS MARKET FOR CARDIOVASCULAR DISEASE DIAGNOSTICS, BY REGION, 2016-2020 (USD MILLION)
TABLE 117 MULTIPLEX ASSAYS MARKET FOR CARDIOVASCULAR DISEASE DIAGNOSTICS, BY REGION, 2021-2026 (USD MILLION)
TABLE 118 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CARDIOVASCULAR DISEASE DIAGNOSTICS, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 119 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CARDIOVASCULAR DISEASE DIAGNOSTICS, BY COUNTRY, 2021-2026 (USD MILLION)
9.3.4 AUTOIMMUNE DISEASES
TABLE 120 PREVALENCE OF SOME AUTOIMMUNE DISEASES
TABLE 121 MULTIPLEX ASSAYS MARKET FOR AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2016-2020 (USD MILLION)
TABLE 122 MULTIPLEX ASSAYS MARKET FOR AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2021-2026 (USD MILLION)
TABLE 123 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR AUTOIMMUNE DISEASE DIAGNOSTICS, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 124 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR AUTOIMMUNE DISEASE DIAGNOSTICS, BY COUNTRY, 2021-2026 (USD MILLION)
9.3.5 NERVOUS SYSTEM DISORDERS
TABLE 125 MULTIPLEX ASSAYS MARKET FOR NERVOUS SYSTEM DISORDER DIAGNOSTICS, BY REGION, 2016-2020 (USD MILLION)
TABLE 126 MULTIPLEX ASSAYS MARKET FOR NERVOUS SYSTEM DISORDER DIAGNOSTICS, BY REGION, 2021-2026 (USD MILLION)
TABLE 127 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR NERVOUS SYSTEM DISORDER DIAGNOSTICS, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 128 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR NERVOUS SYSTEM DISORDER DIAGNOSTICS, BY COUNTRY, 2021-2026 (USD MILLION)
9.3.6 METABOLISM & ENDOCRINOLOGY DISORDERS
TABLE 129 MULTIPLEX ASSAYS MARKET FOR METABOLISM & ENDOCRINOLOGY DISORDER DIAGNOSTICS, BY REGION, 2016-2020 (USD MILLION)
TABLE 130 MULTIPLEX ASSAYS MARKET FOR METABOLISM & ENDOCRINOLOGY DISORDER DIAGNOSTICS, BY REGION, 2021-2026 (USD MILLION)
TABLE 131 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR METABOLISM & ENDOCRINOLOGY DISORDER DIAGNOSTICS, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 132 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR METABOLISM & ENDOCRINOLOGY DISORDER DIAGNOSTICS, BY COUNTRY, 2021-2026 (USD MILLION)
9.3.7 OTHER DISEASES
TABLE 133 MULTIPLEX ASSAYS MARKET FOR OTHER DISEASES, BY REGION, 2016-2020 (USD MILLION)
TABLE 134 MULTIPLEX ASSAYS MARKET FOR OTHER DISEASES, BY REGION, 2021-2026 (USD MILLION)
TABLE 135 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER DISEASES, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 136 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER DISEASES, BY COUNTRY, 2021-2026 (USD MILLION)

10 MULTIPLEX ASSAYS MARKET, BY END USER (Page No. - 133)
10.1 INTRODUCTION
TABLE 137 MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2020 (USD MILLION)
TABLE 138 MULTIPLEX ASSAYS MARKET, BY END USER, 2021-2026(USD MILLION)
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
TABLE 139 MULTIPLEX ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016-2020 (USD MILLION)
TABLE 140 MULTIPLEX ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2026 (USD MILLION)
TABLE 141 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 142 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2026 (USD MILLION)
10.3 HOSPITALS & RESEARCH INSTITUTES
TABLE 143 MULTIPLEX ASSAYS MARKET FOR HOSPITALS & RESEARCH INSTITUTES, BY REGION, 2016-2020 (USD MILLION)
TABLE 144 MULTIPLEX ASSAYS MARKET FOR HOSPITALS & RESEARCH INSTITUTES, BY REGION, 2021-2026 (USD MILLION)
TABLE 145 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR HOSPITAL & RESEARCH INSTITUTES, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 146 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR HOSPITAL & RESEARCH INSTITUTES, BY COUNTRY, 2021-2026 (USD MILLION)
10.4 REFERENCE LABORATORIES
TABLE 147 MULTIPLEX ASSAYS MARKET FOR REFERENCE LABORATORIES, BY REGION, 2016-2020 (USD MILLION)
TABLE 148 MULTIPLEX ASSAYS MARKET FOR REFERENCE LABORATORIES, BY REGION, 2021-2026 (USD MILLION)
TABLE 149 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 150 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021-2026 (USD MILLION)
10.5 OTHER END USERS
TABLE 151 MULTIPLEX ASSAYS MARKET FOR OTHER END USERS, BY REGION, 2016-2020 (USD MILLION)
TABLE 152 MULTIPLEX ASSAYS MARKET FOR OTHER END USERS, BY REGION, 2021-2026 (USD MILLION)
TABLE 153 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 154 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2026 (USD MILLION)

11 MULTIPLEX ASSAYS MARKET, BY REGION (Page No. - 143)
11.1 INTRODUCTION
TABLE 155 MULTIPLEX ASSAYS MARKET, BY REGION, 2016-2020 (USD MILLION)
TABLE 156 MULTIPLEX ASSAYS MARKET, BY REGION, 2021-2026 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 22 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SNAPSHOT
TABLE 157 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 158 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 159 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
TABLE 160 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
TABLE 161 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2020 (USD MILLION)
TABLE 162 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 163 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2020 (USD MILLION)
TABLE 164 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2021-2026 (USD MILLION)
TABLE 165 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
TABLE 166 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
TABLE 167 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2020 (USD MILLION)
TABLE 168 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY END USER, 2021-2026 (USD MILLION)
11.2.1 US
TABLE 169 US: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
TABLE 170 US: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
TABLE 171 US: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2020 (USD MILLION)
TABLE 172 US: MULTIPLEX ASSAYS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 173 US: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2020 (USD MILLION)
TABLE 174 US: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2021-2026 (USD MILLION)
TABLE 175 US: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
TABLE 176 US: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
TABLE 177 US: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2020 (USD MILLION)
TABLE 178 US: MULTIPLEX ASSAYS MARKET, BY END USER, 2021-2026 (USD MILLION)
11.2.2 CANADA
TABLE 179 CANADA: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
TABLE 180 CANADA: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
TABLE 181 CANADA: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2020 (USD MILLION)
TABLE 182 CANADA: MULTIPLEX ASSAYS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 183 CANADA: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2020 (USD MILLION)
TABLE 184 CANADA: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2021-2026 (USD MILLION)
TABLE 185 CANADA: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
TABLE 186 CANADA: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
TABLE 187 CANADA: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2020 (USD MILLION)
TABLE 188 CANADA: MULTIPLEX ASSAYS MARKET, BY END USER, 2021-2026 (USD MILLION)
11.3 EUROPE
TABLE 189 EUROPE: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
TABLE 190 EUROPE: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
TABLE 191 EUROPE: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2020 (USD MILLION)
TABLE 192 EUROPE: MULTIPLEX ASSAYS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 193 EUROPE: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2020 (USD MILLION)
TABLE 194 EUROPE: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2021-2026 (USD MILLION)
TABLE 195 EUROPE: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
TABLE 196 EUROPE: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
TABLE 197 EUROPE: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2020 (USD MILLION)
TABLE 198 EUROPE: MULTIPLEX ASSAYS MARKET, BY END USER, 2021-2026 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 23 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET SNAPSHOT
TABLE 199 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
TABLE 200 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
TABLE 201 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2020 (USD MILLION)
TABLE 202 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 203 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2020 (USD MILLION)
TABLE 204 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2021-2026 (USD MILLION)
TABLE 205 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
TABLE 206 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
TABLE 207 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2020 (USD MILLION)
TABLE 208 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY END USER, 2021-2026 (USD MILLION)
11.5 REST OF THE WORLD
TABLE 209 ROW: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
TABLE 210 ROW: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
TABLE 211 ROW: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2020 (USD MILLION)
TABLE 212 ROW: MULTIPLEX ASSAYS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 213 ROW: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2020 (USD MILLION)
TABLE 214 ROW: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2021-2026 (USD MILLION)
TABLE 215 ROW: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
TABLE 216 ROW: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
TABLE 217 ROW: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2020 (USD MILLION)
TABLE 218 ROW: MULTIPLEX ASSAYS MARKET, BY END USER, 2021-2026 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 173)
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
12.2.1 OVERVIEW OF THE STRATEGIES ADOPTED BY KEY PLAYERS IN THE MULTIPLEX ASSAYS MARKET, 2018 TO 2021
12.3 MARKET RANKING ANALYSIS, 2020
FIGURE 24 MULTIPLEX MARKET SHARE ANALYSIS, 2020
TABLE 219 MULTIPLEX ASSAYS MARKET: DEGREE OF COMPETITION
12.4 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS)
12.4.1 STARS
12.4.2 PERVASIVE PLAYERS
12.4.3 EMERGING LEADERS
12.4.4 PARTICIPANTS
FIGURE 25 MULTIPLEX ASSAYS MARKET (GLOBAL): COMPANY EVALUATION QUADRANT, 2020
12.5 COMPANY EVALUATION QUADRANT (SMES/STARTUPS)
12.5.1 PROGRESSIVE COMPANIES
12.5.2 STARTING BLOCKS
12.5.3 RESPONSIVE COMPANIES
12.5.4 DYNAMIC COMPANIES
FIGURE 26 MULTIPLEX ASSAYS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
12.6 COMPETITIVE SITUATION AND TRENDS
12.6.1 PRODUCT LAUNCHES AND APPROVALS
TABLE 220 PRODUCT LAUNCHES AND APPROVALS, 2018-2021
12.6.2 DEALS
TABLE 221 DEALS, 2018-2021
12.6.3 OTHER DEVELOPMENTS
TABLE 222 OTHER DEVELOPMENTS, 2018-2021

13 COMPANY PROFILES (Page No. - 186)
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1 ILLUMINA, INC.
TABLE 223 ILLUMINA, INC.: BUSINESS OVERVIEW
FIGURE 27 COMPANY SNAPSHOT: ILLUMINA, INC. (2020)
13.2 LUMINEX CORPORATION
TABLE 224 LUMINEX CORPORATION: BUSINESS OVERVIEW
FIGURE 28 LUMINEX CORPORATION: COMPANY SNAPSHOT (2020)
13.3 THERMO FISHER SCIENTIFIC INC.
TABLE 225 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 29 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC INC. (2020)
13.4 BIO-RAD LABORATORIES, INC.
TABLE 226 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 30 COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC. (2020)
13.5 BECTON DICKINSON AND COMPANY
TABLE 227 BECTON, DICKINSON AND COMPANY.: BUSINESS OVERVIEW
FIGURE 31 COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY (2020)
13.6 QIAGEN N.V.
TABLE 228 QIAGEN N.V.: BUSINESS OVERVIEW
FIGURE 32 COMPANY SNAPSHOT: QIAGEN N.V. (2020)
13.7 ABCAM PLC
TABLE 229 ABCAM PLC.: BUSINESS OVERVIEW
FIGURE 33 COMPANY SNAPSHOT: ABCAM PLC (2020)
13.8 MERCK KGAA
TABLE 230 MERCK KGAA.: BUSINESS OVERVIEW
FIGURE 34 COMPANY SNAPSHOT: MERCK KGAA (2020)
13.9 AGILENT TECHNOLOGIES INC.
TABLE 231 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
FIGURE 35 COMPANY SNAPSHOT: AGILENT TECHNOLOGIES, INC. (2020)
13.1 QUANTERIX
TABLE 232 QUANTERIX.: BUSINESS OVERVIEW
FIGURE 36 COMPANY SNAPSHOT: QUANTERIX (2020)
13.11 DIASORIN S.P.A.
TABLE 233 DIASORIN S.P.A.: BUSINESS OVERVIEW
FIGURE 37 COMPANY SNAPSHOT: DIASORIN S.P.A. (2020)
13.12 BIO-TECHNE CORPORATION
TABLE 234 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW
FIGURE 38 COMPANY SNAPSHOT: BIO-TECHNE CORPORATION (2020)
13.13 MESO SCALE DIAGNOSTICS, LLC
TABLE 235 MESO SCALE DIAGNOSTICS, LLC: BUSINESS OVERVIEW
13.14 RANDOX LABORATORIES LTD.
TABLE 236 RANDOX LABORATORIES LTD.: BUSINESS OVERVIEW
13.15 OLINK
TABLE 237 OLINK: BUSINESS OVERVIEW
13.16 OTHER PLAYERS
13.16.1 SEEGENE INC.
TABLE 238 SEEGENE INC.: COMPANY OVERVIEW
13.16.2 PROMEGA CORPORATION
TABLE 239 PROMEGA CORPORATION: COMPANY OVERVIEW
13.16.3 SIEMENS HEALTHINEERS
TABLE 240 SIEMENS HEALTHINEERS: COMPANY OVERVIEW
13.16.4 PERKINELMER INC.
TABLE 241 PERKINELMER INC.: COMPANY OVERVIEW
13.16.5 SHIMADZU CORPORATION
TABLE 242 SHIMADZU CORPORATION: COMPANY OVERVIEW
13.16.6 ANTIGENIX AMERICA, INC.
TABLE 243 ANTIGENIX AMERICA, INC.: COMPANY OVERVIEW
13.16.7 ENZO LIFE SCIENCES, INC.
TABLE 244 ENZO LIFE SCIENCES, INC: COMPANY OVERVIEW
13.16.8 CAYMAN CHEMICAL LTD.
TABLE 245 CAYMAN CHEMICAL LTD.: COMPANY OVERVIEW
13.16.9 BOSTER BIOLOGICAL TECHNOLOGY
TABLE 246 BOSTER BIOLOGICAL TECHNOLOGY: COMPANY OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX (Page No. - 255)
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 AVAILABLE CUSTOMIZATIONS
14.5 RELATED REPORTS
14.6 AUTHOR DETAILS